Neutral
Assessing Jazz Pharmaceuticals (JAZZ) Valuation After Xywav And Ziihera Updates And Strong Quarterly Results
Jazz Pharmaceuticals (JAZZ) has shown strong performance with recent updates on its sleep and oncology portfolios, including Xywav and Ziihera, and be...